Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
xekCTJC39XrZ9Wvj